Literature DB >> 2645986

Premenstrual syndrome: current knowledge and management.

G E Robinson1.   

Abstract

Premenstrual syndrome (PMS) has become a popular self-diagnosis. Faulty research has led to confusion about the diagnosis, epidemiologic features, causes and treatment of this disorder. There is no proof that the premenstrual period is a time of increased violence. An association between menstrually related mood disorders and other psychiatric illness is also unproven. Despite many theories no definitive cause of PMS has been established, and controlled studies of various treatments have failed to find a universally effective approach. Conservative measures involving support, diet and exercise seem to help in most cases. The use of alprazolam and mefenamic acid may help some women. Rectal or vaginal progesterone therapy has been proven ineffective and should not be used.

Entities:  

Mesh:

Year:  1989        PMID: 2645986      PMCID: PMC1268750     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  71 in total

1.  Progesterone treatment of premenstrual tension--a double blind study.

Authors:  B Andersch; L Hahn
Journal:  J Psychosom Res       Date:  1985       Impact factor: 3.006

2.  Behavioural effects after high dose naloxone administration to normal volunteers.

Authors:  M R Cohen; R M Cohen; D Pickar; H Weingartner; D L Murphy; W E Bunney
Journal:  Lancet       Date:  1981-11-14       Impact factor: 79.321

3.  The diversity of premenstrual changes as reflected in the Premenstrual Assessment Form.

Authors:  U Halbreich; J Endicott; S Schacht; J Nee
Journal:  Acta Psychiatr Scand       Date:  1982-01       Impact factor: 6.392

4.  Mood, sexuality, hormones, and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome.

Authors:  T Bäckström; D Sanders; R Leask; D Davidson; P Warner; J Bancroft
Journal:  Psychosom Med       Date:  1983-12       Impact factor: 4.312

5.  Premenstrual mood disorder and psychiatric illness.

Authors:  R DeJong; D R Rubinow; P Roy-Byrne; M C Hoban; G N Grover; R M Post
Journal:  Am J Psychiatry       Date:  1985-11       Impact factor: 18.112

6.  The role of essential fatty acids and prostaglandins in the premenstrual syndrome.

Authors:  D F Horrobin
Journal:  J Reprod Med       Date:  1983-07       Impact factor: 0.142

7.  Prolactin levels in the premenstrual syndrome.

Authors:  P M O'Brien; E M Symonds
Journal:  Br J Obstet Gynaecol       Date:  1982-04

8.  Treatment of common gynecologic-endocrinologic symptoms by allergy management procedures.

Authors:  C R Mabray; M L Burditt; T L Martin; C R Jaynes; J R Hayes
Journal:  Obstet Gynecol       Date:  1982-05       Impact factor: 7.661

9.  Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome.

Authors:  H Schaumburg; J Kaplan; A Windebank; N Vick; S Rasmus; D Pleasure; M J Brown
Journal:  N Engl J Med       Date:  1983-08-25       Impact factor: 91.245

10.  The incidence of premenstrual tension in a gynecologic clinic.

Authors:  J T Hargrove; G E Abraham
Journal:  J Reprod Med       Date:  1982-12       Impact factor: 0.142

View more
  1 in total

1.  Treatment of premenstrual syndrome.

Authors:  R Holland
Journal:  CMAJ       Date:  1989-06-01       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.